Notice on an ordinary shareholders meeting of JSC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Notice on an ordinary shareholders meeting of JSC “Liepājasautobusu parks”

Liepaja, 2014-04-30 13:48 CEST (GLOBE NEWSWIRE) -- Notice on an ordinary shareholders meeting of JSC “Liepājasautobusu parks”  

The firm, registration number and juridical address: Joint stock Company “Liepājas autobusu parks”, registration number 40003015652, addressCukura Street 8/16, Liepaja, LV-3414.  

Number of total share voters: 627 441 shares with voting rights  

Meeting place:   Cukura Street 8/16, Liepaja, at premises of JSC “Liepājas autobusu parks”, 4 room.  

Meeting time: 3 June of 2014, 11:00 o’clock.  

Type of meeting: Ordinary shareholders meeting.  

Shareholders rights to include questions in work order of shareholder meeting:   1) shareholders who own at least 1/20 (one twentieth) of company’s capital stock within sevendays of announcing this notice or within five days after receiving this notice have rights to demand to the company’s board to include additional questions in the agenda of the shareholder meeting; 2) shareholders who propose to include additional questions in the agenda of shareholders meeting, have dutyto submit to company’s board draft decisions about questions that they want to include inagenda of shareholders meeting or explanation about questions in which it is not supposed tomake any decisions.  

Shareholders rights to submit draft decisions for the discussion about the issues included inagenda of the meeting and to ask questions about the issues of the agenda of shareholdersmeeting: 1) shareholders within seven days from the day when the notice about shareholders meeting was distributed, have rights to submit draft decisions to company’s board about questions included in the agenda of shareholders meeting; 2) shareholders have rights to submit draft decisions on questions included in the agenda of the shareholders meeting during the meeting if all questions of the agenda are reviewed and rejected.  

Date of entry: 1) rights to participate in the extraordinary shareholders meeting have only those shareholders who will owncompany’s shares in entry date, in the end of May 26, 2014; 2) shareholders representatives and authorized persons have to show their passports or other identity document at registration, need to submit written warrant of represented shareholder (the warrant form is available on JSC “Liepājas autobusu parks” home pagewww.lap.lv and on Official obligatory information central keeping system internet pagewww.oricgs.lv) or legal representatives need to show document that confirms authority.  

Place and way how shareholders may obtain Company’s disposable draft decisions and forms that are used for voting on the warrant basis: Shareholders have rights to receive draft decisions and forms, which are used for voting on thewarrant basis, without charge from May 20 of 2014 till June 2 of 2014 on Official obligatoryinformation central keeping system internet page www.oricgs.lv and on the JSC “Riga stock exchange”home page http://www.baltic.omxnordicexchange.com/, and also during work days from 9:00 till 16:00o’clock in Liepaja, Cukura Street 8/16, JSC “Liepājas autobusu parks” secretariat, by prior arrangement in previous day by phone 63426778, but on the day of shareholder meeting – at the registration place. The draft decision on 7th question of the agenda is included in this notice.  

Homepage addresses, where this notice is available: 1) www.lap.lv ; 2) www.oricgs.lv ; 3) www.baltic.omxnordicexchange.com.  

Registration of the shareholders: At the day of meeting on June 3 of 2014 from 10:00 till 11:00 o’clock at the shareholders meeting place.  

Work order: 1. Reports of the board of directors, the supervisory board and the sworn auditor about results of 2013. 2. Approval of the annual report 2013: 2.1. approval of the annual report 2013; 2.2. approval of the consolidated annual report 2013. 3. Disposal of earnings of 2013. 4. Approval of the budget and working plan for 2014: 4.1. income; 4.2. expenses; 4.3. planned earning of 2014. 5. The election of the sworn auditor and the determination of the sworn auditor’s remuneration. 6. Denomination of the share capital. 7. An amendment of the Company’s Articles of the Association: 7.1. approval of the amendment of the Company’s Articles of the Association; 7.2. approval of the new version of Company’s Articles of the Association.  

It is supposed to determine July 4 of 2014 as the date of the denomination of Company’s share capital.  

The draft decision on the 7th question of the agenda 7.1. To approve the amendment of the Company’s Articles of Association and express it’s 3rd Article in the fallowing form: “3. SHARE CAPITAL AND CATEGORIES OF SHARES 3.1. Company’s share capital is EUR 878 417.4 (eight hundred seventy eight thousand four hundred seventeen euro and 40 cents. 3.2. Company’s share capital consists of 627 441 (six hundred twenty seven thousand four hundred one) share of which: 3.2.1. 239 900 (two hundred thirty nine thousand and ninety) shares are bearer shares in dematerialized form; 3.2.2. 387 541 (three hundred eighty seven thousand five hundred forty one) share is registered share in paper form which are shares of closed emission. 3.3. The nominal value of one share is EUR 1.40 (one euro and 40 cents).”  

7.2. To approve the Company’s Articles of the Association in the new version.      

Form of power of attorney attached

Board of JSC “Liepājas autobusu parks”     

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 114

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 65

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 20

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 102

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Zura Bio Faces Tough Road After Trial Failure

Updated Category News Views 155

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 56

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 126

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 252

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Charitable Giving Turbocharges E-commerce Conversion Rates

Updated Category News Views 50

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading